Literature DB >> 10593798

The utility of daily therapeutic thoracentesis for the treatment of early empyema.

S Sasse1, T Nguyen, L R Teixeira, R Light.   

Abstract

STUDY
OBJECTIVES: To determine if therapeutic thoracentesis is as effective as early chest tube placement or no drainage procedure in the treatment of early empyema in rabbits. DESIGN AND
INTERVENTIONS: An empyema, as evidenced by gross pleural pus and a decreased pleural fluid pH and glucose level, was induced in 49 rabbits. The rabbits were divided into three groups: 16 underwent daily therapeutic thoracentesis starting at 48 h, 14 underwent chest tube placement at 48 h, and 19 served as controls.
RESULTS: The mortality rate in the therapeutic thoracentesis group (0/16) did not differ significantly from that in the chest tube group (3/14) or that in the control group (6/19). At autopsy at 10 days, the gross empyema score in the therapeutic thoracentesis group (2.1 +/- 0.3) was significantly lower (p < 0.05) than that in the chest tube group (2. 8 +/- 0.3) or the control group (3.5 +/- 0.2). The mean pleural peel score of 5.8 +/- 1.1 in the therapeutic thoracentesis group was significantly less (p < 0.05) than the score for the nonintervention control group (13.4 +/- 1.6).
CONCLUSIONS: From this study, we conclude that therapeutic thoracentesis is at least as effective as early chest tube placement for the treatment of early empyema using our rabbit model of empyema.

Entities:  

Mesh:

Year:  1999        PMID: 10593798     DOI: 10.1378/chest.116.6.1703

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  3 in total

1.  Management of infectious processes of the pleural space: a review.

Authors:  Ankur Girdhar; Adil Shujaat; Abubakr Bajwa
Journal:  Pulm Med       Date:  2012-03-14

2.  Intrapleural use of urokinase and DNase in pleural infections managed with repeated thoracentesis: A comparative cohort study.

Authors:  David Luque Paz; Betsega Bayeh; Pierre Chauvin; Florence Poizeau; Mathieu Lederlin; Mallorie Kerjouan; Charles Lefevre; Bertrand de Latour; Julien Letheulle; Pierre Tattevin; Stéphane Jouneau
Journal:  PLoS One       Date:  2021-09-21       Impact factor: 3.240

Review 3.  From Bedside to the Bench-A Call for Novel Approaches to Prognostic Evaluation and Treatment of Empyema.

Authors:  Sophia Karandashova; Galina Florova; Steven Idell; Andrey A Komissarov
Journal:  Front Pharmacol       Date:  2022-01-20       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.